SHAREHOLDERS' EQUITY:

9 Months Ended

Mar. 31, 2013

SHAREHOLDERS' EQUITY:

SHAREHOLDERS' EQUITY:

5. SHAREHOLDERS’ EQUITY:

Additional Paid-In Capital:

The $13.0 million decrease in additional paid-in capital during the nine months ended March 31, 2013 was due to repurchases of common stock partially offset by stock-based compensation.

In May 2000, the Company’s Board of Directors approved a stock repurchase program. To date, a total of $300.0 million has been authorized to be expended for the repurchase of the Company’s stock. All repurchased shares become authorized but unissued shares of the Company. This repurchase program has no stated expiration date.  During the three months ended December 31, 2012, the Company repurchased 909,175 shares for $14.9 million. There were no share repurchases during the three months ended March 31, 2013. At March 31, 2013, $58.7 million remains outstanding on the approved stock repurchase program.

Accumulated Other Comprehensive Income:

The Company completed the sale of its investment in Provalliance during the quarter ended September 30, 2012 and subsequently liquidated all foreign entities with Euro denominated operations.  Amounts previously classified within accumulated other comprehensive income that were recognized in earnings were foreign currency translation rate gain adjustments of $43.4 million, a cumulative tax-effected net loss of $7.9 million associated with a cross-currency swap that was settled in fiscal year 2007 that hedged the Company’s European operations, and a $1.7 million net loss associated with cash repatriation, which netted to $33.8 million for the nine months ended March 31, 2013, recorded within interest income and other, net on the Condensed Consolidated Statement of Operations.